๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hydroxyurea therapy in chronic myelogenous leukemia

โœ Scribed by B. J. Kennedy

Publisher
John Wiley and Sons
Year
1972
Tongue
English
Weight
401 KB
Volume
29
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Therapy of chronic myelogenous leukemia
Therapy of chronic myelogenous leukemia
โœ Moshe Talpaz; Hagop Kantarjian; Kenneth McCredie; Jose Trujillo; Michael Keating ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 413 KB
Hydroxyurea-Induced gangrene of the toes
Hydroxyurea-Induced gangrene of the toes in a patient with chronic myelogenous leukemia
โœ Yasuda, Norimasa; Ohmori, Sei-ichi; Usui, Tadao ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 148 KB ๐Ÿ‘ 2 views

To the Editor: Semenzato et al. proposed new criteria for large granular lymphocyte (LGL) leukemia because patients with low levels of GL were similar to those with levels greater than 2,000 GL/l [1]. LGL leukemia is a GL proliferative disease often accompanied by pure red cell aplasia (PRCA). T-cel

Chronic myelogenous leukemia presenting
Chronic myelogenous leukemia presenting in blastic crisis
โœ Richard S. Bornstein; Mark Nesbit; B. J. Kennedy ๐Ÿ“‚ Article ๐Ÿ“… 1972 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 297 KB ๐Ÿ‘ 1 views

Chronic myelogenous leukemia (CML) is the only h a m a n neoplastic disease associated with a specific cytogenetic abnormality, the Philadelphia (Phl) chromosome. This marker chromosome is found in the majority of patients with CML and has only occasionally been reported in other hematologic conditi